PacBio

formerly Pacific BiosciencesIPO

PacBio is a biotech company in USA, United States, founded in 2004. It has raised $1.2B across 4 rounds, most recently a $900.0M Convertible Note in February 2021.

Sequence with confidence.

Headquarters
USA, California
Employees
501–1000
Founded
2004
Business Model
B2B
Website
pacb.com
Total Funding
$1.2B
Last Round
$900.0M Convertible NoteFeb 2021
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.

About

PacBio (Pacific Biosciences) develops and manufactures advanced long-read DNA sequencing systems used by researchers worldwide. The company's HiFi sequencing technology delivers 99.9% accuracy across long reads, enabling comprehensive analysis of genomes, transcriptomes, and epigenomes. PacBio serves genomics researchers in human health, agriculture, infectious disease, and biopharma, with its Revio and Vega systems as flagship platforms.

Summary

It lists 501–1000 employees. It has raised $1.2B in total across 4 rounds, most recently a $900.0M Convertible Note round in Feb 2021. Investors include T. Rowe Price, SoftBank and Deerfield Management.

Tech & App Stack

19 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
ConvertibleConvertible NoteFeb 2021
$900.0M

Sign up to see all 5 events

Funding: Growth Equity through Convertible Note. Amounts, valuations, and investors where available.

Investors

Acquisitions

Similar Companies

Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PacBio on Indexed.vc
<a href="https://indexed.vc/companies/pacbio"><img src="https://indexed.vc/api/badge/company/pacbio" alt="PacBio on Indexed.vc" width="260" height="76" /></a>